HomeHLN • NYSE
add
Haleon PLC - ADR
Previous close
$10.08
Day range
$10.02 - $10.09
Year range
$7.70 - $10.80
Market cap
45.31B USD
Avg Volume
6.49M
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 2.78B | 0.84% |
Operating expense | 1.15B | 5.58% |
Net income | 303.00M | 1.68% |
Net profit margin | 10.92 | 0.83% |
Earnings per share | 0.10 | -7.02% |
EBITDA | 718.50M | 3.08% |
Effective tax rate | 22.91% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 531.00M | 8.37% |
Total assets | 33.40B | -2.25% |
Total liabilities | 16.69B | -5.16% |
Total equity | 16.71B | — |
Shares outstanding | 9.13B | — |
Price to book | 5.54 | — |
Return on assets | — | — |
Return on capital | 6.16% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 303.00M | 1.68% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 percent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK.
Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020. Wikipedia
Founded
Jul 18, 2022
Website
Employees
25,408
